
Conference Coverage
about 2 hours ago
Closing the Gap: AON on Whole-Patient Care and Payer Dataabout 8 hours ago
Trispecifics May Widen Myeloma Access: Beth Faiman, PhD, MSNLatest Content

Gene Silencers Cut ATTR-CM Events, Mostly in Patients Off Stabilizers

Review Backs ApoB to Flag Residual Risk That LDL-C Can Miss

Autoimmune Hepatitis Regimens Carry Distinct Adverse Event Signals

FAQ: How Payers Can Close HIV Prevention and PrEP Access Gaps

Medicaid Obesity GLP-1 Coverage May Offset Some Diabetes-Labeled Use

Shorts










Center on Health Equity & Access
All News

HR 1 brings Medicaid work requirements and narrower immigrant eligibility by January 2027, and CBO projects 10 million more uninsured by 2034.

CMS ends ACA subsidies for 189,000 enrollees with duplicate Medicare, Medicaid, or CHIP coverage or listed as deceased, with a 30-day dispute window.

Sjögren disease involves far more than dry eyes and mouth, and variable symptoms plus multispecialty testing delay diagnosis, says Steven Carsons, MD.

SURPASS-CVOT data show fewer deaths or HF events with tirzepatide vs dulaglutide in patients with HF, driven largely by mortality.

Subcutaneous mosunetuzumab plus polatuzumab vedotin boosts responses in relapsed large B-cell lymphoma, helping community oncology care.

Using baseline samples from 177 patients in the VISION/HO141 trial, researchers built a functional prognostic model for CLL that outperformed the CLL-IPI.

Early MASH risk stratification, drug choice, and aligned coverage could improve outcomes, explained Zobair Younossi, MD.

The Franklin County death is under state review as Pennsylvania's measles outbreak passed 1100 cases and 219 hospitalizations.

Among 4378 Spanish registry patients, dyshidrotic eczema was less tied to occupation than other hand eczema.

New non-CF bronchiectasis in Medicare is tied to high health care use and $8998 PPPM FFS spending; prevalence is highest in older women.




























